Cysticercosis
- B69 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM B69 became effective on October 1, 2023.
- This is the American ICD-10-CM version of B69 – other international versions of ICD-10 B69 may differ.
Includes
- cysticerciasis infection due to larval form of Taenia solium
The following code(s) above B69 contain annotation back-references
that may be applicable to B69:
- A00-B99 Certain infectious and parasitic diseases
Clinical Information
- A parasitic infection caused by the larval form of taenia solium. It is a disseminated infection affecting the central nervous system, subcutaneous tissues, lungs, heart and liver. The most serious complications result from infection of the brain parenchyma. Patients may develop seizures, hydrocephalus, encephalopathy and meningoencephalitis.
- Infection with cysticercus, the larval form of the various tapeworms of the genus taenia (usually t. Solium in man). In humans they penetrate the intestinal wall and invade subcutaneous tissue, brain, eye, muscle, heart, liver, lung, and peritoneum. Brain involvement results in neurocysticercosis.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Code annotations containing back-references to B69:
- Type 1 Excludes: B68